<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: The A&gt;G polymorphism at position 19911 of the prothrombin gene is associated with a mildly increased risk of venous <z:hpo ids='HP_0001907'>thromboembolism</z:hpo>, alone or in association with such common <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> mutations as factor V Leiden and prothrombin 20210 GA </plain></SENT>
<SENT sid="1" pm="."><plain>Its role in cerebral sinus-<z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> (CSVT) is not known </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: The presence of prothrombin 19911 A&gt;G was investigated in a case–control study of 107 patients with <z:hpo ids='HP_0005305'>cerebral thrombosis</z:hpo> and factor V Leiden (n = 25), prothrombin 20210 GA (n = 47), without known <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> (n = 35) and 842 healthy individuals with the corresponding coagulation profile </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Prothrombin 19911 A&gt;G did not increase the risk of CSVT in carriers of factor V Leiden (adjusted odds ratio 1.6, 95%CI 0.6–4.7), prothrombin 20210 GA (odds ratio 1.1, 95%CI 0.6–2.2), nor in patients without known <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> (odds ratio 1.3, 95%CI 0.5–3.1) </plain></SENT>
<SENT sid="4" pm="."><plain>CONCLUSIONS: Prothrombin 19911 A&gt;G polymorphism does not appear to be a risk factor for CSVT, alone or in association with factor V Leiden or prothrombin 20210GA </plain></SENT>
</text></document>